Intravenous Solutions Market to Grow at 5.79% CAGR Driven by Growing Popularity of Intravenous Vitamin C Therapy in Cancer Treatment
RnRMarketResearch.com adds Global Intravenous Solutions Market 2016-2020 latest research report, the analysts forecast global intravenous solutions market to grow at a CAGR of 5.79% during the period 2016-2020.
Pune, India – May 27, 2016 /MarketersMedia/ —
The growth of the global intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that are expected to increase the rate of adoption of intravenous solutions among consumers. The rising popularity of intravenous vitamin C therapy in cancer treatment is one of the major trends in the intravenous solutions market. The intravenous vitamin C solution has been observed to have an increased toxicity to cancer cells and improve the patients’ quality of life.
Complete report on intravenous solutions market spread across 53 pages, analyzing 4 major companies and providing 16 data exhibits is now available at http://www.rnrmarketresearch.com/global-intravenous-solutions-market-2016-2020-market-report.html
Global Intravenous Solutions Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
The Intravenous Solutions Market is divided into the Following Segments Based on Geography: Americas, APAC, Europe and MEA
The report also includes a discussion of the key vendors operating in this market. The report covers the present scenario and the growth prospects of the global intravenous solutions market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of various type intravenous fluids:
• Crystalloids
• Colloids
• Free H2O solutions
Order a copy of Global Intravenous Solutions Market 2016-2020 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=582851
The following companies are the key players in the Global Intravenous Solutions Market: Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, and Hospira Inc.
Other Prominent Vendors in the market are: Bioscrip, Claris Lifesciences, Grifols, IV Solutions, JW Life Science, Sichuan Kelun Pharmaceutical, Terumo, Thai Otsuka Pharmaceutical, Omnicare, Vifor Pharma, and Widatra Bhakti.
The infusion of liquid substances, such as nutrients and drugs, directly into a vein is referred as intravenous therapy. Intravenous fluids are extensively used to treat electrolyte imbalances, maintain fluid balance, and replace fluid losses. These fluids are dispensed in volumes ranging from 25-1,000 milliliters and are available in either plastic bags or glass bottles. A complete mixture of all essential nutrients is also available in multi-chamber bags, and these bags are gaining immense popularity among numerous end-users.
Further, the intravenous solutions market report states that the presence of stringent regulations introduced by governments leads to unnecessary delays and additional costs in manufacturing. This hinders the growth of the vendors and, therefore, the market.
Another related report is Global Immunoglobulin Products Market 2016-2020, the analysts forecast global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020. As plasma therapeutics is often expensive, vendors provide co-pay assistance to patients to enable the purchase of these drugs. For instance, Baxter’s Gammagard liquid support program provides financial assistance to individuals with primary immunodeficiency. According to the Gammagard Liquid SubQ CoPay card, an eligible patient receiving treatment with Gammagard Liquid SubQ for primary immunodeficiency is entitled to save up to $2,500 on the coinsurance/co-payment costs over a 12-month period. Browse complete report @ http://www.rnrmarketresearch.com/global-immunoglobulin-products-market-2016-2020-market-report.html
key players in the Global Immunoglobulin Products Market: Baxalta, Biotest Pharmaceuticals Corp., CSL Ltd., Grifols SA, Kedrion SpA, and Octapharma.
Other Prominent Vendors in the market are: Abeona Therapeutics, Admabiologics, Anthera, Beijing Tiantan Biological Products (China), Bharat Serums and Vaccines (India), Bio Products Laboratory, China Biologic Products (China), Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Hualan Biological Engineering (China), Immunomedics, Innate Pharma, Integrated Biotherapeutics, Janssen Pharmaceuticals, Kamada, LFB Group (France), Mitsubishi Tanabe Pharma, Momenta Pharma, Patrys, Shanghai RAAS Blood Products (China), Sichuan Yuanda Shuyang Pharmaceutical (China), and Sorrento Therapeutics.
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
For more information about us, please visit http://www.rnrmarketresearch.com/global-intravenous-solutions-market-2016-2020-market-report.html
Contact Info:
Name: Ritesh Tiwari
Email: sales@rnrmarketresearch.com
Organization: RnRMarketResearch
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar, Pune, Maharashtra 411013, India.
Phone: + 1 888 391 5441
Release ID: 116962
Copyright © 1999-2013 SproutNews.com
